Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 10;7(1):65.
doi: 10.1186/s41687-023-00605-8.

The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough

Affiliations

The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough

Margarita de la Orden Abad et al. J Patient Rep Outcomes. .

Abstract

Background: Refractory chronic cough (RCC), a cough lasting longer than 8 weeks with an unexplained underlying etiology and unresponsive to conventional treatment, can have substantial effects on patients' quality of life. For assessment of the efficacy of antitussive medication in clinical trials in RCC, patient-reported outcome (PRO) instruments should be fit for purpose with appropriate content validity. Here we describe the qualitative testing of a newly developed PRO instrument: the Severity of Chronic Cough Diary (SCCD).

Methods: The SCCD was developed to assess patients' symptom experience of cough in patients with RCC. A preliminary version was tested and refined based on an iterative process in a qualitative study. In total, three rounds of interviews were conducted with adult participants diagnosed with RCC in the USA (n = 19) and UK (n = 10). Rounds 1-3 consisted of hybrid concept elicitation (CE) interviews and cognitive interviews (CIs), with Round 3 also including interviews in a subset of participants (n = 5) about the usability of the SCCD as administered on an electronic handheld device.

Results: The CE interviews identified concepts important to patients' experiences related to RCC that were broadly in line with the concepts in the preliminary version of the SCCD. Participants provided positive feedback on the draft SCCD across all CI rounds, reporting the instrument to be relevant and straightforward to complete, and containing a comprehensive set of concepts to evaluate their symptom experience of RCC. Participants demonstrated a good understanding of proposed item wording, response options, and the 24-hour recall period, and thought completion of the SCCD on the electronic device was easy. Following revisions based on results from each interview round, the SCCD at the end of this qualitative research study had 14 items assessing the concepts of: cough symptoms (five items), symptoms related to cough (four items), disruption to activities due to cough (three items), and disruption to sleep due to cough (two items).

Conclusions: The results of this study provide qualitative evidence supporting the content validity of the SCCD as a PRO instrument for evaluating outcomes of therapies for RCC in clinical trials.

Keywords: Content validity; Diary; PRO; Patient-reported outcome; Qualitative; RCC; Refractory chronic cough; Refractory unexplained chronic cough; Severity of Chronic Cough Diary.

PubMed Disclaimer

Conflict of interest statement

MdlOA and CH are employees of Bayer AG. HK and AS are employees of Evidera, which was contracted by Bayer AG to conduct the study. AH was an employee of Evidera at the time of the study and is now an employee of UCB.

Figures

Fig. 1
Fig. 1
Overview of the steps involved in the development of the SCCD aThis article focuses on Stage 4: assessing the content validity of the SCCD. The preceding Stages 1–3 of SCCD development are briefly described in the Supplementary Information bStage 2 clinical expert interviews were conducted with three clinicians who treat patients with RCC in order to understand the clinical practice experience of symptoms of RCC and to assess the concepts of interest identified in the literature review concepts. Relevant cough severity concepts were obtained and informed the development of the patient interview guide cClinical expert feedback from one of the three clinicians in Stage 2 was also obtained on the SCCD Version 0.1 and Version 0.3 to assess the clinical relevance of the concepts included in the SCCD before the patient interviews CE concept elicitation, CI cognitive interview, RCC refractory chronic cough, SCCD Severity of Chronic Cough Diary
Fig. 2
Fig. 2
Revised conceptual framework of the SCCD Version 1.0 following qualitative research aImportant for women only RCC refractory chronic cough, SCCD Severity of Chronic Cough Diary

Similar articles

Cited by

References

    1. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. doi: 10.1183/13993003.01136-2019. - DOI - PMC - PubMed
    1. Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S, et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J. 2015;45(5):1479–1481. doi: 10.1183/09031936.00218714. - DOI - PubMed
    1. Morice A, Dicpinigaitis P, McGarvey L, Birring SS. Chronic cough: new insights and future prospects. Eur Respir Rev. 2021;30(162):210127. doi: 10.1183/16000617.0127-2021. - DOI - PMC - PubMed
    1. Dicpinigaitis PV, Birring SS, Blaiss M, McGarvey LP, Morice AH, Pavord ID, et al. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough. Ann Allergy Asthma Immunol. 2023;130(1):60–66. doi: 10.1016/j.anai.2022.05.003. - DOI - PubMed
    1. Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, et al. P2 × 3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015;385(9974):1198–1205. doi: 10.1016/S0140-6736(14)61255-1. - DOI - PubMed

Publication types